CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast

首页> 外文期刊>The Indian journal of medical research >CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast

【24h】

CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast

机译：CD3 +，CD4 +和CD8 +肿瘤浸润淋巴细胞（TIL）是乳腺癌浸润性导管癌患者预后良好的预后指标

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Indian journal of medical research》 |2014年第2014期|共页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast. [J] . Ankita Singh Rathore, Sandeep Kumar, Rituraj Konwar, The Indian journal of medical research. . 2014,第3期

机译：CD3 +，CD4 +和CD8 +肿瘤浸润淋巴细胞（TILs）是乳腺癌浸润性导管癌预后良好的预后指标。
2. CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast [J] . Ankita Singh Rathore, Sandeep Kumar, Rituraj Konwar, The Indian journal of medical research . 2014,第3期

机译：CD3 +，CD4 +和CD8 +肿瘤浸润淋巴细胞（TIL）是乳腺癌浸润性导管癌患者预后良好的预后指标
3. Presence of CD3+ tumor infiltrating lymphocytes is significantly associated with good prognosis in infiltrating ductal carcinoma of breast [J] . RathoreA.S., KumarS., KonwarR., Indian journal of cancer. . 2013,第3期

机译：CD3 +肿瘤浸润淋巴细胞的存在与乳腺浸润性导管癌的良好预后显着相关
4. prominent Ttamour-Infiltrating Lymphocytes Improved Disease Free Survival in Early Stage Gastric Carcinoma [C] . C. Staudacher, A. Tain burini, V. Tomajer, International Gastric Cancer Congress . 2005

机译：突出的Ttamour浸润淋巴细胞改善了早期胃癌的无病无病生存
5. Tumor Infiltrating Lymphocyte Therapy for Renal Cell Carcinoma: Methods for ex vivo Expansion and T-Cell Memory Induction [D] . Braun, Mitchell W. 2021

机译：肾细胞癌患者肿瘤浸润淋巴细胞治疗：用于脱型膨胀和T细胞记忆诱导的方法
6. CD3+ CD4+ CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast [O] . Ankita Singh Rathore, Sandeep Kumar, Rituraj Konwar, 2014

机译：CD3 +CD4 +和CD8 +肿瘤浸润淋巴细胞（TILs）是乳腺癌浸润性导管癌预后良好的预后指标
7. Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma [O] . S Han, C Zhang, Q Li, 2014

机译：肿瘤浸润CD4 +和CD8 +淋巴细胞作为胶质瘤临床结果的预测因子

CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast

著录项

相似文献

相关主题

期刊订阅